Head and Neck Cancer Treatment Update: Pembrolizumab, Nivolumab and PD-L1 Markers - 100390

Spotlight
Video

Head and Neck Cancer Treatment Update: Pembrolizumab, Nivolumab and PD-L1 Markers

cancergrace has 938 videos Subscribe Here

Loading........
Description: Drs. Jared Weiss, Assistant Professor, Clinical Research Hematology/Oncology, University of North Carolina School of Medicine, and Josh Bauml, Assistant Professor of Medicine, Hospital of the University of Pennsylvania, join GRACE to discuss updates relating to pembrolizumab, nivolumab and PD-L1 markers for head and neck cancers.
Shared By : cancergrace
Posted on : 04/10/17
Added : 1 year ago